Technologies

Creative Biolabs Expands iPSC Reprogramming and Differentiation Platforms to Advance Disease Modeling

  • by

Creative Biolabs launches expanded iPSC and astrocyte differentiation services to support next‑generation disease modeling and neurobiology research. United States, February 27, 2026 — As stem‑cell–based systems continue to gain traction as more predictive alternatives to… Read More »Creative Biolabs Expands iPSC Reprogramming and Differentiation Platforms to Advance Disease Modeling